Mahsulot tavsifi
Ko-trimoksazol tabletkalari 480 mg is used to treatment of susceptible strains lead to E. coli, klebsiella species, e. coli and proteus, ordinary proteus and Morgan bacterial urinary tract infections caused by susceptible strains. Pneumocystis carinii pneumonia prevention, available for pneumocystis carinii disease patients to hae a history of at least one, or adults infected with HIV, their CD4 lymphocyte count 200 cells/mm3 or less or less than 20% of the total number of lymphocytes.
Dori nomi
Umumiy ism. Ko-trimoksazol tabletkalari
English name. Co-trimoxazole Tablets
Ko-trimoksazol tabletkalari 480 mg Ko'rsatkichlar
Ushbu mahsulotning asosiy ko'rsatkichlari sezgir shtammlar keltirib chiqaradigan quyidagi infektsiyalarni davolashdir.
1. E. coli, klebsiella turlari, e. coli va proteus, oddiy proteus va sezgir shtammlardan kelib chiqqan Morgan bakterial siydik yo'llari infektsiyalari.
2. Streptococcus pneumoniae and haemophilus lead to acute otitis media for 2 years age or older children.
3. Streptococcus pneumoniae va gemofilus kattalardagi surunkali bronxitning o'tkir epizodlariga olib keladi.
4. Pneumocystis carinii pnevmoniyasini davolashda bu mahsulot birinchi navbatda hisoblanadi.
5. Pneumocystis carinii pnevmoniyasining oldini olish, pneumocystis carinii kasalligi bilan og'rigan bemorlarda yoki OIV bilan kasallangan kattalarda mavjud bo'lib, ularning CD4 limfotsitlari soni 200 hujayra/mm3 yoki limfotsitlar umumiy sonining 20% dan kam yoki kamroq.
6. Enterotoxin e. coli (ETEC) lead to tourists diarrhea.
Spetsifikatsiya
480 mg yoki sizning talabingiz bo'yicha
Sifat standarti
BP
Qadoqlash
10 x 10 tabletka / quti
Tayyorgarlik
planshetlar
